Stockreport

MEI Pharma and Kyowa Kirin Announce Global License, Development and Commercialization Agreement for ME-401

MEI Pharma, Inc.  (MEIP) 
Last mei pharma, inc. earnings: 2/6 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.meipharma.com
PDF MEI Pharma and Kyowa Kirin will co-develop and co-promote ME-401 in the U.S.; MEI to book U.S. sales on 50-50 profit and cost sharingKyowa Kirin obtains exclusive commer [Read more]